CDK2-IN-14-d3
CDK2-IN-14-d3 is a potent and selective CDK2 inhibitor. CDK2-IN-14-d3 can be used in research of cancer[1].
Product Specifications
CAS Number
2498658-25-4
UNSPSC
12352005
Target
CDK
Type
Isotope-Labeled Compounds
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
O=S(C1=CC=C(NC2=NC=C(C34CC3)C(N([C@H]5[C@](C)(O)CCC5)C4=O)=N2)C=C1)(NC([2H])([2H])[2H])=O
Molecular Formula
C21H22D3N5O4S
Molecular Weight
446.54
References & Citations
[1]Sokolsky A, et al. Discovery of 5, 7-Dihydro-6 H-pyrrolo [2, 3-d] pyrimidin-6-ones as Highly Selective CDK2 Inhibitors. ACS Medicinal Chemistry Letters, 2022.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Isoform
CDK2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1214327 Inquire
Recombinant Rhodobacter sphaeroides Bifunctional purine biosynthesis protein PurH (purH), partial
Sign In for Pricing
View Details 